Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sorbolene is a non-proprietary emollient and moisturising cream widely used as a topical skin barrier and general-purpose moisturiser. It is officially registered in the British Pharmacopoeia as "Aqueous Cream BP" and consists primarily of hydrocarbon-based ingredients such as paraffin oil (liquid paraffin), white soft paraffin wax, mineral oil, purified water, emulsifying wax (often containing sodium lauryl sulfate), cetostearyl alcohol, chlorocresol (as preservative), and sometimes glycerine. Sorbolene acts by forming an oily layer on the skin surface to trap moisture within the epidermis. It is commonly used to treat or prevent dry skin conditions including eczema, dermatitis, psoriasis, xerosis (dryness), nappy rash in babies, minor irritations from shaving or radiation therapy burns. Its simple formulation makes it suitable for sensitive skin types since it typically lacks perfumes or colorants that may cause irritation[1][2][3][8]. Sorbolene does not have an active pharmacological mechanism but functions physically as a barrier to reduce transepidermal water loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sorbolene.